Literature DB >> 29616463

The influence of comorbidity on the postoperative survival in elderly (≥ 75 years old) with lung cancer.

Tokujiro Yano1, Mototsugu Shimokawa2, Osamu Kawashima3, Mitsuhiro Takenoyama4, Yoshinori Yamashita5, Takeshi Fukami6, Tsuyoshi Ueno7, Eiji Yatsuyanagi8, Seiichi Fukuyama9.   

Abstract

OBJECTIVES: We conducted a multi-institutional prospective observational study of elderly patients (≥ 75 years-old) with resected non-small cell lung cancer. In this report, we have followed the cohorts for 2 years after surgery and examined both the influence of preoperative comorbidity [Adult Comorbidity Evaluation-27 (ACE-27) index] on the postoperative survival and the change in the Karnofsky Performance Status (KPS).
METHODS: From March 2014 to April 2015, 264 patients were prospectively registered from 22 hospitals affiliated with the National Hospital Organization. The mean age at the time of surgery was 79.3 years (range 75-90 years), and 41% of the patients were ≥ 80 years of age. A total of 26% underwent sublobar resection. The study endpoints were the postoperative overall survival (OS), its prognostic factors, and the changes in the postoperative KPS.
RESULTS: The 2-year OS was 85.3% (95% confidence interval 80.4-89.1%). Male gender, age ≥ 80, a smoking history, grade 2 of ACE-27, and an advanced disease stage were significantly poor prognostic factors for the OS in the univariate risk analysis. The multivariate analysis showed that male gender, age ≥ 80, an advanced disease stage and sublobar resection were significantly poor prognostic factors for the OS. In comparison with the preoperative KPS, no marked decline was observed in the postoperative chorological change of KPS.
CONCLUSIONS: In the surgical treatment of elderly patients, the comorbidity as assessed by the ACE-27 index might affect the postoperative survival, and therefore should be taken into accounts in the preoperative evaluation of the surgical indications.

Entities:  

Keywords:  Adult Comorbidity Evaluation-27; Karnofsky Performance Status; Non-small cell lung cancer; Postoperative survival; Surgery

Mesh:

Year:  2018        PMID: 29616463     DOI: 10.1007/s11748-018-0919-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  18 in total

1.  The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis.

Authors:  T Yano; H Yokoyama; Y Fukuyama; E Takai; K Mizutani; Y Ichinose
Journal:  Eur J Cardiothorac Surg       Date:  1997-03       Impact factor: 4.191

Review 2.  Risk assessment of lung resection for lung cancer according to pulmonary function: republication of systematic review and proposals by guideline committee of the Japanese association for chest surgery 2014.

Authors:  Noriyoshi Sawabata; Takashi Nagayasu; Yoshihisa Kadota; Taichiro Goto; Hiroyoshi Horio; Takeshi Mori; Shinichi Yamashita; Akinori Iwasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-09-27

3.  Lobar and sub-lobar lung resection in octogenarians with early stage non-small cell lung cancer: factors affecting surgical outcomes and long-term results.

Authors:  Andrea Dell'Amore; Marco Monteverde; Nicola Martucci; Stefano Sanna; Guido Caroli; Giampiero Dolci; Davide Dell'Amore; Gaetano Rocco
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-11-18

4.  Lung cancer surgery in patients aged 80 years or older: an analysis of risk factors, morbidity, and mortality.

Authors:  Naoko Miura; Mikihiro Kohno; Kensaku Ito; Mayuko Senba; Koutarou Kajiwara; Naohiko Hamaguchi; Hideki Makino; Takanori Kanematsu; Tatsuro Okamoto; Hideki Yokoyama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-04-14

5.  Comparison of Scoring Methods for ACE-27: Simpler Is Better.

Authors:  Dorina Kallogjeri; Jay F Piccirillo; Edward L Spitznagel; Ewout W Steyerberg
Journal:  J Geriatr Oncol       Date:  2012-07-01       Impact factor: 3.599

6.  Surgical treatment of non-small cell lung cancer in octogenarians.

Authors:  Olivia Fanucchi; Marcello Carlo Ambrogi; Paolo Dini; Marco Lucchi; Franca Melfi; Federico Davini; Alfredo Mussi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-02-05

7.  Differential prognostic impact of comorbidity.

Authors:  William L Read; Ryan M Tierney; Nathan C Page; Irene Costas; Ramaswamy Govindan; Edward L J Spitznagel; Jay F Piccirillo
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

8.  Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Alessandro Brunelli; Anthony W Kim; Kenneth I Berger; Doreen J Addrizzo-Harris
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Prognostic importance of comorbidity in a hospital-based cancer registry.

Authors:  Jay F Piccirillo; Ryan M Tierney; Irene Costas; Lori Grove; Edward L Spitznagel
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

10.  Survival following segmentectomy or lobectomy in elderly patients with early-stage lung cancer.

Authors:  Yang Zhang; Chongze Yuan; Yawei Zhang; Yihua Sun; Haiquan Chen
Journal:  Oncotarget       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.